Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Organisation › Details

Heidelberg Pharma GmbH

Heidelberg Pharma GmbH is an independent drug development company with several compounds under clinical development. The company concentrates on the pre-clinical and clinical development of unique and innovative therapeutics for the treatment of HIV infection and cancer. The company's business model is based on two pillars: 1) Development of its own pipeline projects through phase II clinical investigations (clinical proof of efficacy) followed by outlicensing for further development and commercialization. 2) Heidelberg Pharma also offers design and development of enhanced pro-drugs for the treatment of cancer and HIV / AIDS from basic compounds provided by partners. *


Period Start 1999-02-19 splitoff (MBO)
Period End 2017-10-18 renamed
  Group Heidelberg Pharma (Group)
  Today Heidelberg Pharma Research GmbH
  Predecessor Heidelberg Pharma AG [old, before 201103]
  Successor Heidelberg Pharma Research GmbH
Products Industry drug development technology
  Industry 2 pharmaceutical
Person Person Schmidt-Brand, Jan (Wilex 201404– CEO before CFO + Heidelberg Pharma 200109– CEO + CFO)
Region Region Ladenburg
  Country Germany
  Street 101 Schriesheimer Str.
  City 68526 Ladenburg
  Tel +49-6203-1009-0
    Address record changed: 2013-01-11
Basic data Employees B: 11 to 50 (2013-01-07)
    * Document for �About Section�: 
Record changed: 2019-12-03


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for Heidelberg Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top